Bradley J. Bolzon PhD - Insider Trading & Ownership

Entity
Individual
Location
One Sansome Street, Suite 3630, San Francisco, California
Summary
The estimated net worth of Bradley J. Bolzon PhD is at least $178 M dollars as of June 10, 2022. Bradley J. Bolzon PhD is the Director, 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $169 M. Bradley J. Bolzon PhD is the Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $9.3 M.
All Insider Reports
All Insider Reports

Ownership of Bradley J. Bolzon PhD

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. Director, 10%+ Owner $169 M Jun 28, 2021
CRSP CRISPR Therapeutics AG Director $9.3 M Jun 9, 2022
BDTX Black Diamond Therapeutics, Inc. Director, 10%+ Owner Jun 18, 2021

Insider Transactions Reported by Bradley J. Bolzon PhD:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership